NCT04316936View on ClinicalTrials.gov

Omidria and Dexycu, or Omidria and Dextenza Compared to Topical Prednisolone Acetate 1% Following Cataract Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 10, 2019

Primary Completion Date

December 23, 2020

Study Completion Date

December 23, 2020

Conditions
Cataract Surgery
Interventions
DRUG

Omidria

phenylephrine 1% and ketorolac 0.3% intraocular solution

DRUG

Dextenza (dexamethasone ophthalmic insert) 0.4mg

intracanalicular dexamethasone insert

DRUG

Dexycu, 9% Intraocular Suspension

dexamethasone intraocular suspension

DRUG

Prednisolone Acetate 1%

standard postoperative ophthalmic drop regimen

Trial Locations (1)

64133

Silverstein Eye Centers, Kansas City

Sponsors

Collaborators (1)

Ocular Therapeutix, Inc.
All Listed Sponsors
collaborator

Ocular Therapeutix, Inc.

INDUSTRY

lead

Silverstein Eye Centers

OTHER